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INTRODUCTION/BACKGROUND 
 	  
Mammalian cortical development 
The cerebral cortex is a highly organized structure comprised of different types of 
neurons and diverse range of glia. Layer-specific neurons are produced earlier 
during development in an inside-out manner followed by the glial cells, as the 
complexity of the mammalian brain is sequentially established through a 
multistep process. The development of this complex brain architecture however 
begins from a common pool of neural precursor cells, where the differentiation 
potential of the cells progressively reduces or the cell acquires different fate 
potential during various stages of development (Molyneaux et al., 2007). This is 
accomplished by maintaining the expression of certain genes in an active state 
and/or by maintaining other genes in a repressed state, in the presence or 
absence of extracellular signaling molecules. Recent studies has shown that this 
could be achieved by some modifications, affecting either DNA or histone 
proteins, altering the state of chromatin and thereby making the DNA more or 
less accessible to the various transcription factors (Hirabayashi et al., 2010). 
Scientists have coined a term for these modifications as “epigenetic 
modifications”. 
Epigenetic modifications 
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Epigenetic modifications are of three types: DNA methylation, Histone 
modifications and non-coding RNA mediated regulations, where the former two 
modifications has been widely studied in relation to cell fate determination and 
cell differentiation. Genome-wide profiling studies of pluripotent stem cells and 
differentiated adult cells shows that chromatin remodeling occurs throughout 
differentiation and plays a major role in determining the state of a cell at any 
given time during differentiation (Chen et al., 2014). This is mainly accomplished 
by establishing a transient repression or a long-term repression on the 
developmental genes, depending on the stages of development (Hirabayashi et 
al., 2010). Earlier during development, transient/reversible repression helps to 
keep several genes in a poised state until appropriate signals initiate their 
differentiation towards different lineages. However, long-term/permanent 
repression of developmental genes comes into play once the cell lineage has 
been defined and restricts their differentiation potential to alternative lineages by 
permanently repressing a set of genes, which are generally expressed in 
alternative lineages. These repressions are normally epigenetic and the 
epigenetic mechanisms that are mainly associated with repression are DNA 
methylation and histone methylation (Kouzarides, 2007).  
Histone methylation 
Nucleosomes are the fundamental unit of chromatin, consisting of an octamer of 
histone core proteins around which the DNA is wrapped. The part of these core 
proteins, which is of great importance, is the N-terminal “tail” as they possess 
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large number of residues that can be modified in eight distinct ways (Kouzarides, 
2007). These modifications dictate the assembly and package of chromatin, 
which in turn determines their interactions with other non-histone proteins and 
thereby influencing different biological processes such as DNA repair, 
transcription, replication and gene expressions (Kouzarides, 2007). Of these 
modifications, methylation is considered to be the most characterized 
modification and methyltransferase enzyme is the most specific along with the 
kinases, amongst all the histone modifying enzymes. Histone methyltransferases 
catalyze the transfer of a methyl group/groups to either an arginine or a lysine 
residue, thereby activating or repressing the transcription depending on the 
residues being methylated. The first mammalian histone lysine 
methyltransferase(HKMT) to be identified was Suv39h1, known to target H3K9, 
contained the Su(var)3,9-Enhancer of zeste-Trithorax (SET) domain, the catalytic 
domain for lysine methylation (Rea et al., 2000). This discovery led to the 
identification of several other HKMTs in various species. Among the other 
methyltransferases, identification of G9a and GLP is considered to be of 
biological significance. 
Role of HKMTs in neurogenesis 
Studies in mice have demonstrated the significant role played by the HKMTs in 
the process of neurogenesis. Ezh2, enhancer of zeste homolog 2, is associated 
with gene repression by catalyzing the trimethylation of lysine residue 27 in the 
tail of histone H3. Deletion of Ezh2 before the onset of cortical neurogenesis 
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resulted in disrupting the balance between self-renewal and differentiation, by 
switching the balance towards differentiation, where neurons and basal 
progenitors were produced at the expense of self-renewal. The deletion also 
affected the switch between gliogenesis and neurogenesis by reducing the time 
window in which the neurons were generated and resulted in reduced production 
of neurons (Pereira et al., 2010). Similarly another study showed that, deletion of 
Setdb1, a histone trimethyltransferase, methylating lysine 9 of histone H3, in the 
mouse forebrain resulted in smaller cortex and increased production of deeper 
layer neurons at the expense of upper layer neurons. This proved that deletion of 
Setdb1 is essential for early neurogenesis and it regulates neurogenesis by 
repressing the expression of non-neuronal genes during development (Tan et al., 
2012). 
G9a/GLP 
G9a/ Eu-HMTase2 and GLP/Eu-HMTase1 are members of the Suv39h subgroup 
of SET-domain containing molecules, which are known to form a heteromeric 
complex via their SET domain that methylates the H3K9 residue in vivo (Collins 
et al., 2010). Studies demonstrate that the mammalian Suv39h1 acts as a crucial 
lysine methyltransferase for H3K9me3 on pericentromeric heterochromatin 
region (Rea et al.,2000), however G9a is the only mammalian H3K9me1 and 
H3K9me2 HKMT known to establish transcriptional silencing in the euchromatic 
regions and is also known to methylate H1 histone protein and other non-histone 
proteins (Tachibana et al., 2001). G9a is an enzyme, which has separate 
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domains for “reading” and “writing” the methylation marks. It “reads” via its 
ankyrin repeat domain, through which it can interact and bind to the H3K9me1 
and H3k9me2 marks and “writes” through it SET domain (Collins et al., 2008) 
(Fig i). 
 
Recent studies have demonstrated the pivotal role played by G9a in diverse 
mammalian biological processes. G9a plays an essential role in the early 
embryogenesis of mice as deletion of G9a results in lethality of embryos around 
day E9.5 due to growth retardation (Tachibana et al., 2001). G9a also plays a 
(i) Domain organization of G9a components. G9a consists of 
an automethylation site in the N-terminal domain, the ankyrin 
repeat domain (binds to H3K9me1 and H3K9me2) and a 
catalytic SET domain involved in mono and dimethylation of 
H3K9 histone residue and binds to GLP protein (adapted 
from Collins et al., 2010) 
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role in maintaining the differentiation status of postmitotic neurons (Katoh et al., 
2012; Schaefer et al., 2009), as deletion of G9a resulted in derepression of non-
neuronal and neural progenitor genes causing complex behavioral changes in 
these mice and most recent studies implicate G9a has a role in the specification 
of neuronal subtypes in striatum (Maze et al., 2014). However the exact role of 
G9a during brain development has not been studied before, partly because of the 
reason that G9a deletion resulted in early embryonic lethality (Tachibana et al., 
2001). Hence we sought to study the role of G9a in cerebral cortical development 
by restricting its deletion to progenitors originating in Emx-1 lineage. This was 
possible as we obtained a G9a floxed animal, where the exons 26, 27/28 
responsible for the HMTase activity can be targeted for a cre recombinase-
mediated deletion (Tachibana et al., 2007). We thus took advantage of the cre-
loxP system in generating our desired G9a conditional knockout by crossing this 
G9a flox animal with Emx-1-cre transgenic mice as shown in the Fig ii-A. Ablating 
G9a during cortical development resulted in reduced cortical growth. However the 
laminar organization was preserved in these animals. These animals also 
exhibited signs of aggression and hyper-excitability. Overall, our data suggests 
that G9a is necessary for proper development of cerebral cortex and could also 
have a potential role in regulating the social behavior of animals. 
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Figure (ii) Strategy for generating G9a conditional knockout. (A) We crossed 
G9a floxed animal with an animal expressing cre-recombinase under the Emx-1 
promoter. This would result in the deletion of G9a in brain regions expressing the 
X-gal staining, olfactory bulb (O), neocortex (Cx) and Hippocampus (H) while the 
G9a expression in other regions such as thalamus (T), cerebellum (C), brain 
stem (B) and spinal cord (S) would remain unaffected. The image adapted from 
Iwasato et al., 2000, shows the X-gal staining in a sagittal brain section from a P7 
mouse expressing LacZ under Emx-1 promoter. (B) The image adapted from 
Gorski et al., 2002, shows the X-gal staining in a coronal brain section from a 
E12.5 mouse expressing LacZ under Emx-1 promoter. MP, medial pallium, DP, 
dorsal pallium, VP, ventral pallium, LP, lateral pallium, OT, olfactory tuberculum, 
LGE, lateral ganglionic eminence, MGE, medial ganglionic eminence. 
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MATERIALS AND METHODS 
I. Generation of G9a CKO mice 
G9aflox/flox animal used in this study was obtained from Yoichi Shinkai lab, Kyoto 
University, Japan. The strategy for generating G9a flox conditional mutant allele 
mice was previously described as shown in Figure iii. This animal was crossed 
with Emx-cre transgenic mice obtained from Jackson laboratories. Genotyping 
was performed using tail biopsy and PCR using the following primers: mGE28R 
(GCTCCAGGGCGATGGCCTCCGCTGAATGC); G3 (GGGCCAGCTCATTCCTC 
CACTC) and mGI27-2F (CGGGACAGGGTTTCTCTGTGTAGTCC) as shown in 
Figure 1. 
 
Figure iii: Strategy for generating G9a conditional KO mice. The partial map 
of G9a targeting vectors is shown. The strategy involved flanking exons 26 and 
fused 27/28 exons with loxP sites, followed by the generation of G9a floxed 
animal after introducing the targeting vector into ES cells. Exons, filled rectangles, 
loxP sites, filled triangles, H, Hind III; E, EcoRI. (Adapted from Tachibana et al., 
2007) 
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II. Animal Use 
All animal procedures were performed in accordance with protocols approved by 
the University of Connecticut Institutional Animal Care and Use Committee 
(IACUC) and conform to National Institutes of Health guidelines. The animals 
used in this study were euthanized using isofluorane. 
III. Western Blot Analysis 
Protein extracts from the cerebral cortex were collected from P2 WT and G9a 
CKO mice. Tissues were homogenized in a lysis buffer (50mM Tris, pH 7.5, 0.5M 
NaCl, 1% NP40, 1%DOC, 0.1% SDS, 2mM SDS, 2mM EDTA and complete 
Protease inhibitor cocktail (Sigma, 8340)). Lysates were centrifuged at 
13,000rpm for 15 min at 40oC and the supernatants collected. The protein 
concentrations were determined using BCA Assay kit (Thermo Scientific, 23227).  
Equivalent amounts of protein (40 μg) were run on 7.5% Tris-glycine gel and the 
proteins were transferred onto polyvinylidene difluoride Immoblilon Transfer 
membranes (Millipore, Bedford, MA) at 350 mA for 1.5 hr. Membranes were 
blocked overnight at 4oC in 1% casein in Tris-buffered saline solution. 
Immunoblotting was performed with the following antibodes: rabbit anti-G9a 
(1:500; Abcam Cat# ab31874) and mouse anti-GAPDH (1:1000; Sigma Cat# 
G8795) dissolved in casein blocker and incubated overnight at 4oC. The 
membrane was washed several times with TBS-Tween. The secondary 
antibodies used were IRDye anti-mouse and anti-rabbit antibodies (1:10000; LI-
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COR Biosciences) diluted in casein blocker and incubated at room temperature 
for 2 hours. The membranes were again washed several times with TBS-Tween, 
followed by TBS solution. The proteins were detected by LI-COR Odyssey 
Imaging system. 
IV. Immunohistochemistry analysis 
Forebrains from WT and G9a cKO animals were examined at the following ages: 
E14, E19, P2 and P30. All embryonic brains and P2 brains were collected into 
cold HBSS (Invitrogen) and fixed with 4% paraformaldehyde in 0.1M phosphate 
buffer using the immersion fixation technique, whereas postnatal brains beyond 
P2 were perfused with 4% PFA and stored in PBS until further processing. Brains 
were sectioned using both vibratome and cryostat. The samples were 
cryoprotected, embedded, frozen, and sectioned at 20μm thickness on a cryostat 
in coronal sections, which were slide mounted. Similarly 60μm thick coronal free-
floating sections were obtained from postnatal brains using Leica vibratome. The 
sections were subjected to heat-induced epitope retrieval before the 
immunostaining procedures, where the sections were cooked at 90oC for 5-10 
mins in a steamer using an antigen retrieval buffer (Tris/EDTA pH 9.0, sodium 
citrate pH 6.0). The slides were allowed to cool down and washed with PBS 
before incubation in a blocking buffer (4% normal goat serum and 0.1% Triton X-
100 in PBS). The primary antibodies used on sections were as follows: rabbit 
anti-G9a (1:500; Abcam Cat# ab31874), mouse anti-H3K9me2 (1:500; Millipore 
Cat# 07-212), rabbit anti-H3K9me (1:500; Abcam Cat# ab9045), rabbit anti-TBR1 
	   11	  
(1:500; Abcam Cat# ab31940), mouse anti-Satb2 (1:400; Abcam Cat# ab51502), 
and mouse anti-Ctip2 (1:1000; Abcam Cat# ab28448), rabbit anti-Cux1 (1:300; 
Santa cruz Cat# sc-13024). The primary antibodies were diluted in blocking 
solution and the sections were incubated overnight at 4oC. Sections were washed 
with PBS three times for 10 minutes and incubated with secondary antibodies for 
1 hour at room temperature.  Secondary antibodies used were as follows: Alexa 
Fluor goat anti-rabbit IgG (H+L) (Molecular Probes) and Alexa Fluor goat anti-
mouse IgG (H+L) (Molecular Probes). DAPI (Molecular Probes) were used for 
labeling nuclei. Sections were observed and imaged under a laser confocal 
microscope (Leica TCS SP2). Montage images were obtained using Carl Zeiss 
Axio Imager microscope with Apotome and processed using Adobe Photoshop 
CS2. 
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RESULTS 
I. Validation of G9a conditional knockout mice 
To investigate the in vivo epigenetic function of G9a in the developing 
cerebral cortex, we restricted the ablation of G9a to cerebral cortex using 
a Cre-loxP system. G9a floxed animal was crossed with Emx1-cre 
transgenic mice in which Cre-mediated recombination occurs mainly in 
progenitors generated in the dorsal pallium. We obtained G9aloxP/loxPEmx-
cre+/- mice as our G9a cKO mice in the F2 generation. Frequency of 
different genotypes obtained from this crossing was consistent with the 
expected Mendelian ratios, indicating that none of the G9a cKO mice were 
dying embryonically or perinatally. The actual loss of G9a was confirmed 
using the below mentioned techniques: 
 
(i) Genotyping 
The initial genotyping was performed by PCR analysis of tail DNA, 
using the following pair of primers (Figure 1A). The first pair of primers 
(mGI27-2F and mGE28R, Fig 1A, upper panel) was used for wild-type 
G9a allele detection. The second pair of primers (G3 and mGE28R, 
Fig 1A, bottom panel) was used for flox G9a allele detection. Both the 
primer pairs help in distinguishing the homozygous, heterozygous 
mutants and wild type animals. Every experimental animal used in this 
study was genotyped using these two sets of primers and using Emx1-
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cre genotyping primers recommended by Jackson Laboratory. Figure 
1B illustrates that the PCR amplification product of size 500bp denotes 
a G9a wildtype mouse, band size of 450 bp denotes a G9aflox 
homozygous mouse and presence of both the bands represents a 
heterozygous mouse. The presence of Cre transgene was indicated by 
a band size of 100bp. The absence of Cre can be tested using the 
324bp band size following PCR analysis, while the heterozygous 
animals are detected using band sizes of 100bp and 324bp. A PCR 
sample with water was used as a negative control to prevent any false 
positive amplification. 
 
(ii) Western Blot 
Western blot analysis using a G9a antibody demonstrated the partial 
loss of G9a in the cerebral cortices of G9a cKO animals compared to 
their wild type littermates (Figure 1C). The reason for us not seeing a 
complete loss of G9a is discussed later in this section.  
 
(iii) Immunohistochemistry 
To confirm the loss of G9a protein expression in the G9a cKO animals, 
we performed immunohistochemical analysis of coronal brain sections 
of control P2 animals and compared them with G9a cKO animals. At 
postnatal day 2, G9a is expressed nearly in all the cells, including 
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neurons and glial cells present in the cerebral cortex (Figure 1D, upper 
panel). In G9a cKO animals, we observed a cell-type specific deletion 
of G9a, where 75% of cells showed loss of G9a protein. However 25% 
of cerebral cortical cells still expressed G9a (Figure 1D, lower panel). 
This could be due to the incomplete recombination of the floxed allele, 
as previous studies shows that Emx1 gene is not expressed 
ubiquitously in all cortical neurons and the deletion efficiency using the 
Emx1-cre transgenic mice has been around 85-90% (Chan et al., 1999, 
Guo et al., 2000). The other 10-15% cells showing immunopositivity for 
G9a could be due to the fact that these neurons failed to undergo 
proper cre-mediated recombination due to low levels of Cre protein 
expression (Tsien et al., 1996). These results help us in validating the 
deletion of G9a in the neocortex of G9a cKO animals. 
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Figure 1: Generation of G9a Conditional Knockout mice: A) The partial map 
of G9a locus, showing the G9a WT and Floxed allele, in which exons 26, fused 
27/28 and PGK-neo cassette are flanked by two loxP sequences. Exons, filled 
rectangles, lox-P sequences, unfilled triangles. Arrows indicates the forward and 
reverse primers, denoting their approximate hybridization position along the 
alleles and the expected band size for the corresponding PCR reactions. B) PCR 
genotyping carried out using the above mentioned primer pairs. Genotyping 
results shown for different genotype combinations for G9a and Emx-cre animals. 
C) Western blot analysis of P2 cerebral cortical lysates obtained from P2 control 
and G9a cKO animals show the major G9a band at 160 kDa in the wildtype brain 
and partial loss of immunoreactivity in the KO mouse brain (n=2). D) Conditional 
cell-specific deletion of G9a in cerebral cortex. Expression of G9a in the cerebral 
cortex of control (upper panel) and G9a cKO mice (lower panel) at P2. G9a was 
expressed ubiquitously in the control animals as shown by the red nuclear signal. 
G9a expression was lost in most of the cells in G9a cKO animals (arrow), 
however some cells were still expressing G9a (block arrow). Blue staining 
indicates nuclear dye. Scale bar, 20 μm. 
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II.  Loss of G9a resulted in reduced H3K9me2 levels in G9a-deficient 
cells 
Studies on histone lysine methyl transferases (HKMTases) started gaining 
biological significance since the identification of the first mammalian HKMT, 
Suv39h. This also led to the identification of G9a, which was associated with 
euchromatic gene silencing in mammals and had a stronger HMTase activity 
compared to Suv39h (Tachibana et al., 2002). Its loss resulted in a global loss of 
H3K9 methyl levels in euchromatic regions, however H3K9me3 levels in 
heterochromatic regions were unaffected by the loss of G9a (Rice et al., 2003). 
G9a possess a SET domain flanked by two cysteine rich regions in its carboxyl 
terminal, through which it exerts its HMTase activity. In our study, the exons 
responsible for encoding this catalytic SET domain are flanked by loxP 
sequences. Hence Cre-mediated deletion of these exons would result in the loss 
of HKMTase activity in the G9aflox animal before the onset of neurogenesis. Thus 
the H3K9me2 levels were analyzed using coronal brain sections from both 
control (Figure 2A) and G9a cKO animals. Consistent with the previous studies, 
deletion of G9a resulted in a loss of H3K9me2 levels in the cerebral cortex of 
G9a cKO animals (Figure 2B). However a small percentage of cells expressing 
G9a are also positive for H3k9me2 suggesting that G9a is the major histone 
dimethytransferase in the cerebral cortex and SET domain is essential for its 
HMTase activity. In addition to this, surprisingly deletion of G9a also resulted in 
small reduction in the levels of H3K9me in G9a cKO animals (Figure 2D). This 
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could be indicative of a possible role of G9a in monomethylation of the H3 lysine 
residue along with other HMTases, which could compensate for the loss of G9a. 
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Figure 2: Conditional ablation of G9a results in loss of H3K9 dimethylation 
and small reduction in H3k9 monomethylation levels. A) Expression of G9a 
(red signal) and H3K9me2 (green signal) in the P2 WT cerebral cortex. B) Loss 
of H3K9me2 (green signal) only in cells lacking G9a (red signal) indicating that 
G9a is the major dimethyltransferase in the cerebral cortex. C) Expression of 
H3K9me (green signal) in P2 WT cerebral cortex. D) H3K9me levels show a 
slight reduction in cortex of G9a cKO mice indicated by the green signal. Blue 
staining indicates nuclear dye. Scale bar, 20 μm. 
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III. Region specific deletion in G9a cKO animals 
Vertebrate cerebral cortex primordium, which is otherwise called as pallium, is 
divided into four primary progenitor zones, medial, ventral dorsal and lateral. 
Each of these zones gave rise to different regions in a developed brain, 
hippocampus, amygdala, neocortex and piriform cortex respectively (Puelles et 
al., 2000). It has also been established that these regions give rise to glumatergic 
projection neurons and glial cells while the interneurons originating and 
tangentially migrate from the subpallial regions into the cortex during 
development (Marin and Rubenstein, 2001). In this strategy, we have used a 
transgenic mouse strain in which the Emx1 promoter drives the Cre recombinase. 
Emx1 expression is restricted to medial, dorsal and lateral pallial progenitor cells 
and postmitotic neurons originating from these zones, and is not expressed in the 
ventral pallium. By E12.5, all cells present in these zones should have undergone 
successful recombination and similarly we achieved deletion of G9a, which was 
confirmed by immunocytochemistry for both G9a and H3K9me2 at day E12.5 
(Fig 2 A-D). The pattern of deletion observed in our G9a cKO is consistent to the 
expression pattern of a reporter under Emx-1 promoter as shown in a study 
before (Fig ii-B). Moreover this study also indicates that interneurons originate 
outside the Emx-1 lineage and account for 20% of the cortical population. This is 
consistent to the number of cells still expressing G9a in our cKO cerebral cortex 
and sections also show some scattered cells around the LGE region, which 
appear to be migrating from these regions into the cortex (Figure 3 A-D). The 
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same pattern exists in adult animals following development, as G9a deletion is 
restricted to the cortex. G9a expressions in cells present in the striatum, which 
originate from the subpallial regions, remain unaffected following recombination 
in G9a cKO (Figure 3E-H). 
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Figure 3: Region-specific deletion of G9a in cKO: (A-D) Coronal 
sections from G9a cKO showing double immunostaining for G9a (red 
signal) and H3K9me2 (green signal) at embryonic ages E14. This 
confirms the region-specific deletion of G9a, only in cells originating from 
Emx1-lineage. The cells that are still positive for G9a/H3k9me2 might be 
interneurons and cells populating layer 1(MZ), as they originate outside 
the progenitor zones that do not fall under Emx1-lineage. Unfilled arrows 
indicate the scattered cells, which could be possibly migrating from 
subpallial regions into cortex. (E-H) Conservation of this pattern in the 
striatum of postnatal animals. This was confirmed by immunostaining for 
G9a (red signal) and H3K9me2 (green signal) at postnatal day 2. (A’-D’) 
Inset shows the cells at higher magnification. Scale bar, 20 μm (A-D); 25 
μm (E-H).  
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IV. Phenotypic characterization of G9a cKO animals 
Following the generation of a G9a conditional knockout where we successfully 
deleted the G9a in the cerebral cortex, we wanted to see if these animals 
exhibited any gross phenotype. The animals were fertile; survive to adulthood 
and mate successfully giving rise to progeny except for the male mice as they 
exhibited aggressive and self-mutilating behavior. This resulted in them being 
housed separately or together with the same female as they caused self-inflicting 
injuries or serious injuries to other animals housed along with them. Eventhough 
these animals were easily excitable and hyperactive, they did not show any signs 
of spontaneous seizures or hyper-excitability, based on the electrophysiological 
data recorded using G9a cKO animals and control littermates (data not shown). 
Hyper-exicitability, spontaneous seizures and epilepsy have been mainly 
associated to loss or presence of abnormal interneurons (Sarkisian et al., 2001). 
Absence of these phenotype suggests that interneuron population are not 
affected by the loss of G9a in our conditional knockout animals, as they are 
generated from subpallium from where they migrate into the overlying cortex 
during development and do not fall under the Emx-1 lineage (Gorski et al., 2002).  
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V. Cerebral-cortex specific G9a deficient animals exhibit cortical 
thinning 
The cerebral cortices of P2 G9aloxP/loxPEmx-cre+/- animals were considerably 
thinner compared to their wildtype littermates, G9aloxP/wtEmx-cre+/- (Fig 4, Upper 
panel). Quantification of G9a loxp/loxp / Emx1-Cre and G9a loxp/loxp / Emx1-Cre 
cortical thickness at P2 (n=7) indicated a significant reduction in radial thickness 
in somatosensory barrel region of cortex by approximately 20% (601 + 17 µm vs 
497 + 19 µm: two tailed t test p=0.00175). The cortical thinning increased in adult 
G9a cKO animals, P30 (Fig 4, Bottom panel). These results were consistent with 
our previous studies where it was shown that loss of Citron kinase in rats, a Rho-
GTPase activated kinase, known to have a role in cytokinesis, resulted in 
microcephaly (Di cunto et al., 2000). It has also been shown that CitK interacts 
with G9a for maintaining the epigenetic status during the neuronal lineage 
formation by repressing several genes involved in the neuronal development and 
differentiation (unpublished data). This cortical thinning phenotype observed in 
G9a cKO animals is consistent with the microcephaly phenotype seen in Cit-K 
mutants. However G9a-cKO animals did not replicate all the phenotype 
characteristics of Cit-K mutants. This could be due to that the fact that CitK 
mutants completely lacked CitK expression and G9a deletion has been restricted 
to the cerebral cortex in our model. 
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Figure 4: Reduced cortical growth in G9a cKO mice: Coronal brain 
hemisphere DAPI- stained sections from P2 and P30 a G9aloxP/loxPEmx-cre+/- 
animals showing thinner cortex when compared to a G9aloxP/loxPEmx-cre-/- 
littermates. Scale bar 150μm in upper panel, 500μm in bottom panel. 
 
	   27	  
VI. Laminar organization was partially preserved in G9a conditional 
knockout postnatal animals 
Cortical thinning in G9a cKO animals persuaded us to study the laminar 
organization in these animals, as we wanted to see if deletion of G9a altered the 
process of neurogenesis. In spite of cortical thinning, the G9a cKO animals did 
not exhibit any abnormal laminar pattern and the relative positions of different 
laminar markers such as Cux1, Tbr1 were partially conserved in postnatal 
animals (Fig 5).  This laminar patterning is again consistent to the Cit-K mutant 
models, as partial conservation was observed in these mutants. Even though the 
G9a cKO and WT animals exhibited similar laminar organization; there was a 
slight decrease in the number of neurons occupying layer 2/3 (Fig 5 A, B) and 
layer 6(Fig 5 C), based on the Cux1 and Tbr1 immunopositivity, corresponding to 
their smaller brain sizes. 
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Figure 5: Preservation of laminar organization in G9a cKO animals: 
(A) Immunofluorescence for upper layer marker Cux1 (red) on 60µm thick 
sections of P2 and (B) P30 knock out (right panels) and wild type (left 
panels) (C) Immunofluorescence for deep layer marker Tbr1 (red) on 
20µm thick sections of P2 knock out (right panels) and wild type (left 
panels. Scale bar, 100 µm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   30	  
VII. Cortical thinning and preservation of laminar markers was also 
observed during embryonic ages in G9a cKO 
The major aim of this study was to identify the role of G9a in early and late 
cortical neurogenesis. We were also interested in capturing the time window 
during which the cortical thinning might set in the G9a cKO animals. For this 
purpose, we analyzed the brains of G9a cKO at embryonic time points E14 and 
E19.  Cortex-specific deletion of G9a was observed as early as embryonic age 
E12 (Fig 2 A, A’), which is consistent with the other deletion studies performed 
using Emx1-cre transgenic system (Fig ii-B). The cortical thinning was visible at 
age as early as E14 (Fig 6A) and it started becoming more apparent around age 
E19 (Fig 6B). In spite of the reduced cortical growth, the laminar organization 
was preserved in both the ages. Corresponding to the smaller cortices, the 
neuronal population occupying upper and deeper Satb2, Tbr1, Ctip2 positive 
layers were proportionately reduced in G9a cKO animals (Fig 6A, B). 
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Figure 6. Cortical thinning and laminar preservation in embryonic ages: (A) 
Reduced cortical thickness at E14 in G9a cKO.  Immunofluorescence for deep 
layer maker Tbr1 (green) in wild type (left panel) and cKO (right panel) and 
immunofluorescence was performed for deep layer marker Ctip2 (red) on wild 
type (left panels) and cKO (right panels). (B) Immunofluorescence of Satb2 (red) 
on 20µm sections of E19 knock out (right panel) and wild type (left panels). Scale 
bar, 25 µm (A), (B) bottom panel, 100 µm (B) top panel. 
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DISCUSSION 
In the current study, we analyzed the consequence of deleting G9a in the 
cerebral cortex. Analyzing the in vivo role of G9a using G9a-deficient mice was 
hindered as complete deletion of G9a resulted in embryonic lethality (Tachibana 
et al., 2001). However, the gene-targeting strategy devised in previous studies 
(Tachibana et al., 2007) helped in eliminating the histone methyltransferase 
activity of G9a using cre-mediated deletion. Using this strategy, we generated a 
conditional knockout mouse in which the G9a expression was deleted in cells 
originating from the dorsal, medial and lateral pallium. We achieved both region-
specific and cell-specific deletion of G9a, and G9a expression was unaffected in 
other subcortical regions. However 25% of cells present in G9a cKO cerebral 
cortex were still expressing G9a. These cells might have originated from 
ganglionic eminence, which falls outside the Emx-1 specific progenitor zones, 
and would have migrated into the cortex later during development. Also inefficient 
recombination of the floxed allele could also be a reason for these to be still 
positive for G9a. Cre-mediated deletion studies using Emx-1-IRES-Cre 
transgenic mice shows only 85-90% recombination efficiency and an additional 
10% reduction in efficiency of neurons has been attributed to low level 
expression of cre proteins in these neurons (Gua et al., 2000). Analyzing the 
percentage of cells that are double-positive for G9a and a interneuronal marker 
such as parvalbumin, somatostatin, calretinin, in G9a conditional knockout 
animals would help us better understand if these cells showing G9a 
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immunopositivity are from different lineage or a product of inefficient 
recombination or both. 
G9a, a histone methyltransferase found in mammals, associated with H3K9 
methylation-mediated silencing of genes present in the euchromatic regions 
(Tachibana et al., 2001).  This repressive mark of G9a has shown to be essential 
during the process of cellular differentiation and for maintaining the post-mitotic 
status of cells. G9a deletion in a distinct set of striatal neurons led to the up-
regulation of transcriptional programs observed in a different set of neurons, 
along with the acquisition of their electrophysiological properties, thus proving the 
role of G9a in specifying neuronal subtype identity (Maze et al., 2014). G9a is 
also associated with silencing of neuronal genes in non-neuronal regions and 
deletion of G9a in postnatal neurons has resulted in ectopic expression of non-
neuronal genes and neural progenitor genes in post-mitotic neurons. G9a carries 
out all these functions through its HMTase domain. Thus loss of G9a is mostly 
accompanied by loss of H3K9me2-mediated silencing of these genes.  Our study 
also demonstrated that deletion of G9a resulted in a loss of H3K9me2 levels in 
cerebral cortex. This suggests the fact that G9a could be the major histone 
dimethyltransferase in cerebral cortex. We also observed that H3K9 
monomethylation levels were slightly affected by the loss of G9a. This might 
suggest that G9a is not the major histone monomethyltransferase enzyme in the 
neocortex and there could be other SET domain containing lysine 
methytransferases involved in maintenance of H3K9me levels in the brain.  
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Study in our lab has reported that citron kinase, a small Rho-GTPase, known to 
have an important role in both cytokinesis and neurogenesis, establishes the 
repressive marks on developmental genes involved in neuronal development 
through G9a (Sarkisian et al., 2001). Previous study demonstrates that loss of 
citron kinase in rat results in defective neurogenesis and smaller brain size in 
mutants (Di Cunto et al., 2000). Thus, we hypothesized an in vivo role of G9a in 
cortical development and deletion of G9a would affect the brain architecture. We 
observed cortical thinning in our G9a conditional knockout animals, which 
correlated well with the phenotype of CitK-/- mutants reported in the study by Di 
Cunto et al. Cortical thinning was observed as early as E14 in G9a cKO animals 
which became more pronounced as age progressed. Partial preservation of 
laminar organization was another feature found to be common between both the 
mutant models. In spite of these common phenotypes, our G9a cKO neocortex 
did not have any binucleate cells, a hallmark of CitK mutants. This is not 
surprising, as G9a, unlike CitK, has not been implicated in the process of 
cytokinesis regulation. We also did not observe the characteristic neurological 
phenotype in our G9a cKO, epilepsy and lethal seizures, which were present in 
CitK mutants. Abnormal interneuron development was attributed to these 
characteristics in CitK mutants. Lack of this phenotype suggests that the 
interneuron development was unaffected by G9a deletion, thereby further 
validating the fact that we achieved region- or cell type- specific deletion of G9a 
in our cKO. Even though the animals did not show any signs of spontaneous 
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seizures or epilepsy, the G9a cKO male animals exhibited hyper-aggressiveness 
and excitability. The male animals displayed aggression towards intruders and 
caused self-inflicting wounds or injured the intruder, be it male or female. This 
suggests a possible role of G9a in regulating the social behavior or adaptive 
behavior. A previous study suggests that deletion of G9a/GLP in postnatal 
neurons resulted in abnormalities including cognitive impairment and defective 
behavior (Schaefer et al., 2009). A copy of EHMT1/GLP gene is deleted in 
chromosome 9q34 in subtelomeric deletion syndrome patients resulting in severe 
mental retardation. In addition to mental retardation, 9q34 syndrome patients also 
exhibit aggressive behavior and hyper-excitability (Kleefstra et al., 2009). These 
results suggest a possible role of G9a in controlling the social behavior of 
individuals along with cognitive and adaptive behavior. This aggressive nature 
might be due to the global loss of G9a in cerebral cortex or could be restricted to 
the loss of G9a in specific neuronal population, for e.g. neurons present in the 
olfactory bulb of these animals, could have resulted in this aggressive phenotype. 
Olfaction is an important requirement for social recognition and social cognition in 
mice.  G9a cKO animals might have neurons, which are impaired and are unable 
to respond to appropriate olfactory cues due to loss of G9a. This ultimately would 
have resulted in this behavior, which could be an interesting topic for future. This 
would help us in elucidating a possible role of G9a in regulating the social 
behavior of animals. Also these results could be extrapolated to human mental 
retardation syndrome, if we know the fact that deficiency of G9a/GLP in specific 
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brain regions during development causes complex behavioral abnormalities in 
mice.  
The major objective of this study was to identify the role of G9a in cerebral 
cortical development. G9a cKO mimics Ezh2-cKO in terms of cortical growth and 
neuronal layer production in postnatal animals. Both G9a and Ezh2 are 
methyltransferases, known to silence genes by methylating different lysine 
residues of histone core protein H3 and has shown to have a similar role in many 
cellular processes. Ezh2 is responsible for the enzymatic activity of the PRC2 
complex, and study has shown that G9a and Ezh2 control common set of genes, 
which are mainly involved in neuronal differentiation processes. Also G9a 
methylation activity is required for the recruitment of PRC2 complex to these 
genes (Mozetta et al., 2014). These results along with the similarities in 
phenotype between G9a-cKO and Ezh2-cKO animals shed some light on the 
possible role of G9a in cortical development. Thus I would like to hypothesize the 
potential role of G9a in cerebral cortical development: G9a-mediated histone 
methylation is necessary for the initial repression of several neuronal genes that 
are turned on later during the initial stages of neuronal development. However, 
loss of G9a in our cKO could remove these repressive marks, possibly leading to 
up-regulation of several genes including several transcription factors and genes 
that are normally expressed in differentiating neurons. This might result in two 
conditions: (1) the cells instead of self-renewal are directed towards 
differentiation and (2) the G9a cKO animals start making differentiated neurons at 
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an earlier time point compared to the wildtype, thereby accelerating the 
neurogenesis, which might also reduce the neurogenic output. Deletion of Ezh2 
resulted in the up-regulation of these genes at E12.5:  NeuroD6, Myt1L, Bcl1 1b, 
Reelin, Tbr1, Foxp2, Brn2, Lmo4, Satb2 (Pereira et al., 2010). Thus similar up-
regulation could be expected in our G9a cKO and depending on which 
transcription factor genes are upregulated, it could result in the production of 
those neuronal subtypes at an earlier timepoint during development, thereby 
producing less number of neurons, however the temporal order in which these 
neurons are produced might not be affected by loss of G9a. Thus microarray 
analysis and quantitative analysis of neurons populating different layers would 
give us more insight on the exact role of G9a in cerebral cortical development. 
Lack of repressive marks especially on genes coding for different transcription 
factors could direct the neurogenesis more towards differentiation than self-
renewal, thereby reducing the number of neurons produced, but conserving the 
pattern in which they might populate different layers during development. 
Thus our study has demonstrated that deficiency of G9a in neural progenitors 
during cerebral cortical development has resulted in reduced cortical outgrowth 
and minor behavioral anomalies, indicating that G9a is essential for normal 
cortical development and for regulating social behavior in mice. 
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